Pharmafile Logo

Creative Biogene

Creative Biogene is the leading global client service and solutions provider for scientific research, and is committed to the development, manufacture and purification of recombinant adenoviruses, adeno-associated virus (AAV) and lentivirus for gene delivery and gene knock down. With above 20 years of gene delivery tools development experience, Creative Biogene is specialized in providing gene delivery and gene knock down services that cover the full scope of biotechnology needs of early drug discovery and drug development.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.

View Profile

Innovative Trials

Innovative Trials is a leading global clinical trial patient recruitment company. With over 10 years’ of experience, Innovative Trials deploys ‘boots-on-the-ground’ recruitment experts in over 70 countries, addressing individual sites’…

View Profile

Company Details

45-16 Ramsey Road Shirley, New York, NY 11967, United States
+1 631 624 4882

 Latest Content from PMHub 

Medscape Education and M4RD: Together Caring for Rare Disease

We are excited to finally share our news-style video ' ', developed in partnership with Medics 4 Rare Diseases (M4RD) and produced by Genetic Alliance UK and ITN Business.For more information on...

The Need for and Impact of Rare Disease Education

Press Releases | February 28, 2023 | Medscape Education

Physicians are often told that when they hear hoofbeats, think horses, not zebras — to look for the most common cause of a patient’s symptoms first. While this advice may...

Pharmaceutical companies reduce own greenhouse gas emissions, but action on supply chains needed

Press Releases | February 27, 2023 | Oxford PharmaGenesis

DPhil student, Dr Amy Booth (University of Oxford) and Oxford PharmaGenesis CEO, Dr Chris Winchester, have co-authored a new study published in the International Journal of Environmental Research and Public...

Kate Shaw comments the appointment of an independent review on clinical trials in the UK.

Press Releases | February 27, 2023 | Innovative Trials

The news comes after a report by the Association of the British Pharmaceutical Industry (ABPI) highlighted a 44% decline in industry clinical trials in the UK over the last five...

Medscape Education: Rare Diseases Fibrodysplasia Ossificans Progressiva

Rare Disease Day is on February 28.Listen to Nicky explain her daughter's journey with fibrodysplasia ossificans progressiva.Many patients face long waits for accurate diagnosis and treatment, making it critically important...

Medscape Education: Rare Diseases

It's only a few days until #RareDiseaseDay2023 on 28th February. We're taking a patient centered approach, this means understanding their journey so we can better understand how we can help to...

Insight Gathering for Life Science Companies

Videos and Podcasts | February 23, 2023 | Impetus Digital

Virtual engagement experts helping life science companies have ongoing conversations with their customers through our best-in-class online collaboration tools. Best-In-Class CollaborationTechnology Impetus Digital provides two turn-key software solutions through the Impetus...

Rare Diseases – not as rare as you think

Julie Cox reflects on our passion working in the rare disease space - helping to bring vital education to healthcare professionals, to benefit patients

Patient Recruitment: Think Global, Act Local

Global clinical trials are a vital component of pharma R&D. Utilizing sites in multiple countries not only provides increased access to eligible and diverse patients - and therefore more robust...

Together Caring for Rare Disease

Medscape Education and Medics4RareDisease are partnering on a Rare Disease Day awareness campaign. The campaign will form part of a series of short programs produced by ITN in collaboration with Genetic Alliance...